Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

ClinicalTrials.gov ID: NCT00002227

Public ClinicalTrials.gov record NCT00002227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 5:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Open-Label, Multicenter Study to Characterize the Effectiveness and Safety of Efavirenz in Combination With Stavudine and Lamivudine in Antiretroviral Therapy-Naive HIV-Infected Patients

Study identification

NCT ID
NCT00002227
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dupont Merck
Industry
Enrollment
60 participants

Conditions and interventions

Conditions

Interventions

  • Efavirenz Drug
  • Lamivudine Drug
  • Stavudine Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Richard Elion Washington D.C. District of Columbia 20009
The Whitman Walker Clinic Washington D.C. District of Columbia 20009
Community Research Initiative of New England Brookline Massachusetts 02445
Remington Davis Inc Columbus Ohio 43215
The Milton S Hersey Med Ctr / Div of Hematology Hershey Pennsylvania 170330850
Coastal Carolina Research Ctr Mt. Pleasant South Carolina 29464
Montrose Clinic Houston Texas 77006
Hampton Roads Med Specialists Hampton Virginia 23666

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002227 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →